Document is current

Article History

Accepted: 28 August 2024

First Online: 22 September 2024

Declarations

:

: The study protocol was approved by the Institutional Review Board of Siriraj Hospital under two separate approvals: MU-MOU CoA 628/2022 and MU-MOU CoA 650/2023. Informed consent agreements were obtained from all participants.

: Not applicable.

: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

: The model employed in this study was made available to the journal’s peer reviewers for their consideration during the manuscript review process. Additional details about the model can be obtained from the corresponding author upon reasonable request.

: Tanawan Kongmalai, Juthamas Prawjaeng, Phorntida Hadnorntun, Pattara Leelahavarong, Usa Chaikledkaew, Ammarin Thakkinstian, and Varalak Srinonprasert have thoroughly reviewed and disclosed all relevant information. They confirm that there are no financial or non-financial interests, such as professional interests, personal relationships, or personal beliefs, that could be perceived as influencing the work reported in this manuscript. This disclosure is made in strict accordance with the journal’s guidelines to ensure full transparency and prevent any potential bias in the research presented.

: This work is part of the training towards a PhD degree in HTA for which a scholarship is provided by Mahidol University and the International Decision Support Initiative (iDSI) through a grant awarded to UC (OPP1087363). The iDSI supports countries in their efforts to get the best value from their health spending. The iDSI receives funding support from the Bill & Melinda Gates Foundation, the UK Department for International Development, and The Rockefeller Foundation. This work was also supported by the Medicine Regulations Division of the Food and Drug Administration, Ministry of Public Health, Thailand, and was conducted at the request of the NLEM Subcommittee. This study is part of the overarching “Economic Evaluation of Add-On SGLT2i to Standard Treatment in T2D with Congestive HF in Thailand” project, which was used to support the policymaking process under the Subcommittee for the Development of the NLEM in Thailand through the Health Economic Working Group (HEWG), although the HEWG is not responsible for the study findings or the dissemination of research funds. The funders had no role in the study design, data collection, management, analysis, interpretation of the data, preparation of the manuscript, or decision to submit the article for publication.

: TK, PL, UC, and VS conceptualized the original idea and design of the study methodology. TK, PL, and VS obtained the funding. TK, PL, JP, and PH participated in primary and secondary data collection. TK and PL performed the data analysis and interpretation. TK wrote the first draft of the manuscript. TK, PL, AT, UC, and VS critically revised the manuscript. VS provided supervision. All authors read and approved the final version.